23
May

08:00 AM ET

Drug Discovery Biology

Name: Drug Discovery Conferences East Coast 2023
Start: 2023-05-23T08:00
End: 2023-05-23T16:50
Location: Hyatt Regency Princeton

Strategy Meeting East Coast USA 2023

Pushing our understanding of the physiological context and quality of drug target characterisation, validation, and safety profiling throughout the preclinical space

Hyatt Regency Princeton

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Biology Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered. Proventa International’s R&D Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Biology professionals from across the East Coast, in Princeton, New Jersey, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our upcoming strategy meeting.

Aaron Mackey

Former SVP, AI & Data Science Sonata Therapeutics

Abhijat Vatsyayan

Head of Artificial Intelligence Taiho Oncology

Andrew Zhang

Director, Head of Chemical Biology AstraZeneca

Angela Huang

Founder and President Tempo Bioscience

Christopher Conway

President, Research and Development Curia

Chris is a seasoned business executive with a 25 year strong track record across a variety of industry verticals including aerospace, pharmaceutical/biotech and contract research, development, and manufacturing. Chris is highly experienced in P&L leadership, sales, and marketing having worked in large and small, public and private equity backed companies. Currently, Chris serves as President and R&D Business Unit Head at Curia, a global top ten organization in contract research, development and manufacturing services, serving the pharmaceutical/biotech industry. Chris also currently serves as a Director on the board of two Life Sciences organizations including Viyash Life Sciences Private Limited, a Carlyle owned company, as well as the Drug, Chemical & Associated Technologies Association, Inc. (DCAT). Chris received his B.S. in Marketing & Management from Siena College and his Doctorate of Humane Letters from the Albany College of Pharmacy and Health Sciences

Claudette Fuller

Vice President, Head of Non-Clinical Safety & Toxicology Genmab

Douglas Kitchen

Research Fellow, Medicinal Chemistry Curia

Ernane Souza, PhD, RPh

Assistant Director, Translational PKPD and DMPK Supernus Pharmaceuticals Inc

Frank Leu

Founder & Managing Member/ Managing Member BioPharMatrix LLC/ Novapeutics LLC

Greg Williams

Senior Research Scientist II, Cellular Assay Technologies Curia

Dr. Gregory Williams, Senior Research Scientist II, joined Curia in 2020. He serves as the Cell- Based Assay Technologies (CBAT) team leader at Curia’s Integrated Drug Discovery facility in Buffalo, NY. Dr. Williams and his team work to develop cell-based models of human disease using a combination of approaches to support both large-molecule and small-molecule discovery. He has over 10 years’ experience in cell-based assay development and screening of small molecules and has managed more than 150 client based projects in the fields of immunology, oncology, and neurobiology. Leveraging state-of-the-art high content screening tools, automation, and multiplex analysis approaches, Dr. Williams and his team work towards delivering innovative, predictive, and cost-effective assays that drive pre-clinical drug discovery programs. Dr. Williams received his PhD in Biochemistry at the University at Buffalo, where he published work in journals such as Cell and Nature. As a Government of Ireland Postdoctoral Fellow, he investigated the role of small-molecule histone deacetylase inhibitors in the progression of Huntington’s disease at the National University of Ireland in Galway.

Dr. Grant Carr

Vice President, Head of Global R&D Drug Discovery Curia

Gunaretnam Rajagopal

Venture Partner Samsara Biocapital

Guna’s expertise encompasses the fields of Data Sciences, AI/Machine Learning, Bioinformatics, Computational, Systems Biology & Pharmacology, Genetics & Genomics, High Performance Computing and Theoretical & Computational Physics. He has led global initiatives focused on advancing cross-disciplinary basic research, translational & clinical programs in collaboration with academia and national/international pre-competitive consortiums. Guna’s academic career spans undergraduate degree from the University of Malaya (1986), PhD in Computational & Theoretical Physics from Georgia Tech (1987-1991), post-doctoral training at the Cavendish Laboratory, University of Cambridge, rising to Assistant Director of Research and elected a Fellow of Jesus College Cambridge (1991-2000). He was the founding Executive Director of the Bioinformatics Institute at the BIOPOLIS, Singapore (2000-2007), led the Bioinformatics & Systems Biology program at the Rutgers Cancer Institute of New Jersey with a joint appointment as Adjunct Professor at the Robert Wood Johnson Medical School and as a Member of Advanced Studies in Princeton (2007-2012). He joined Janssen R&D to lead efforts to develop and deploy Computational Analytics, Informatics and Data Science capabilities to support global discovery, translational, development and clinical programs (2012-2022). He retired as Scientific Fellow and Global Head of Computational Sciences and joined Samsara Biocapital as a Venture Partner.)

Marcie Glicksman

Vice President, Biology Enclear Therapies

Mark Tornetta

VP of Biologics Discovery Tavotek Biotherapeutics

ML Ujwal

Associate Director, Data Science Johnson & Johnson

Nikolaos Tezapsidis

President & CEO Neurotez Inc.

Paul Kayne

Vice President, Biological Sciences Palatin Technologies

See the agenda and facilitator line-up. Download the strategy meeting brochure for full details.

DOWNLOAD THE BROCHURE

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

There’s only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter

Senior Decision Makers

All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Personalised Agendas

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we’ll create a personalised agenda just for you

Private and Intimate Networking

Small group discussions, private meetings, networking drinks – however you choose to make those important connections our Strategy Meetings have the solution

Our Agenda

See Which Topics Are Discussed at the Strategy Meeting

09:00

Roundtable Tracks

Target Identification & Hit Validation Leveraging the Power of Multi-Omics in Drug Discovery: Maximizing the Potential in Target Identification and Safety Profiling -Paul Kayne Vice President, Biological Sciences, Palatin Technologies DMPK / ADME & Toxicology New Approaches To Predict ADME And Toxicity Of Compounds -Marie C. Fortin Director, Toxicology, Jazz Pharmaceuticals In Vivo and In Vitro Pharmacology In Vivo and In Vitro Pharmacology Advances to Maximize Preclinical Drug Discovery -Junji Matsui Head, Discovery Evidence Generation Function Deep Human Biology Learning (DHBL), Eisai In Silico Biology In Silico Modeling And Simulations In Drug Discovery -Rumin Zhang Vice President, Head of Biochemistry, Volastra Therapeutics Strategic Partnerships & Collaborations Why Integrating Deep Scientific Expertise Matched With Operational And Business Strategy Is Key For Attracting Investment In Early Stage Drug Discovery -Guna Rajagopal Venture Partner, Samsara BioCapital

11:10

Roundtable Tracks

Target Identification & Hit Validation Strategic Guide To Maximize Value: Identifying The Ideal Partner, Formulating The Best Negotiation Strategy And Deal Structure -Nikolaos Tezapsidis President & CEO, Neurotez Inc. DMPK / ADME & Toxicology Predictive Model For Preclinical ADMET: New Modalities, Performance And Applications -Gondi Kumar FORMER Senior Vice President, Nonclinical, Bristol-Myers Squibb In Vivo and In Vitro Pharmacology Developing And Improving Preclinical Dose Projection And Prediction For Further Clinical Studies -Sanae Yasuda Head of Clinical Pharmacology Science, Eisai In Silico Biology Leveraging AI For Drug Discovery Through Different Modalities -Danielle Greenawalt Scientific Executive Director, Informatics & Predictive Sciences, Bristol-Myers Squibb Strategic Partnerships & Collaborations Maximizing Capital Efficiency By Balancing Internal Capabilities And External CRO’s -Di Zhang Founder and Vice President, Tavotek Biotherapeutics

13:10

Roundtable Tracks

Target Identification & Hit Validation Selection Of Appropriate Modalities And Hit ID Strategies For Fic Targets -Mark Tornetta VP of Biologics Discovery, Tavotek Biotherapeutics DMPK / ADME & Toxicology Toward A Unifying Paradigm In Drug Discovery: BK + PK = PD Rumin Zhang Vice President, Head of Biochemistry, Volastra Therapeutics In Vivo and In Vitro Pharmacology And In Vitro Pharmacology: Challenges, Applications And Limitations (TBC) -Kate Excoffon VP Research, Spirovant In Silico Biology In Silico Biology Through Omics Data: Interpretation, Integration And Application In Drug Discovery -Aaron Mackey VP Head of AI/ML, Sonata Therapeutics Strategic Partnerships & Collaborations Why Are CRO M&A Deals On The Rise? How Expanding Full Service Capabilities, Through A Strategic M&A Process Brings Global Efficiencies To Sponsors -Matthew Rosenberg Advisor, Guxi Capital

Become an official strategy meeting partner. Whatever your business needs, we can help. Get in touch for partnering opportunities.

I’D LIKE TO PARTNER

Press play to hear what your colleagues had to say...

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

R&D Princeton

Drug Discovery Biology

Strategy Meeting East Coast USA 2023

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Hyatt Regency Princeton

Fresh Biology Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Meet Our Facilitators

Aaron Mackey

Abhijat Vatsyayan

Andrew Zhang

Angela Huang

Christopher Conway

Claudette Fuller

Douglas Kitchen

Ernane Souza, PhD, RPh

Frank Leu

Greg Williams

Dr. Grant Carr

Gunaretnam Rajagopal

Marcie Glicksman

Mark Tornetta

ML Ujwal

Nikolaos Tezapsidis

Paul Kayne

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

Senior Decision Makers

Personalised Agendas

Private and Intimate Networking

Our Agenda

See Which Topics Are Discussed at the Strategy Meeting

Opening Keynote

Roundtable

Roundtable Tracks

Networking/1-1 Meetings

Roundtable

Roundtable Tracks

Networking Lunch

Roundtable

Roundtable Tracks

Networking/1-1 Meetings

Networking/1-1 Meetings

Drinks Reception

Our Co-Host Sponsor

Our Key Opinion Leader

Press play to hear what your colleagues had to say...

Want to find out more?

Here To Help

Select days you wish to attend You can add multiple days

Daily Delegate Rate includes:

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Hyatt Regency Princeton